INmune Bio Inc. (INMB)
INmune Bio Inc. develops immunotherapies that target innate immune responses in cancer and Alzheimer’s. The company’s platforms aim to modulate inflammation without immune suppression. Progress in clinical trials and partnerships supports growth. Chart
iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics focuses on developing next-generation immuno-oncology therapies. Its lead candidates aim to block cancer’s ability to suppress immune responses. Pipeline advancement and collaborations with large pharma firms drive momentum. Chart
Verastem, Inc. (VSTM)
Verastem, Inc. is a biopharmaceutical company focused on cancer therapies that target tumor growth pathways. Its lead programs aim at solid tumors with limited treatment options. Growth is driven by regulatory progress and ongoing clinical studies. Chart
Follow Trade Ideas on 